Trials / Completed
CompletedNCT04288401
Prevalence of Osteosarcopenic Obesity in Older Adults
Prevalence of Osteosarcopenic Obesity in Older Community-dwelling Adults in Turkey
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 460 (actual)
- Sponsor
- Istanbul Medeniyet University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population
Conditions
Timeline
- Start date
- 2020-02-25
- Primary completion
- 2020-03-31
- Completion
- 2020-04-01
- First posted
- 2020-02-28
- Last updated
- 2020-05-19
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04288401. Inclusion in this directory is not an endorsement.